Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Apyx Medical Corporation stock

Own Apyx Medical Corporation stock in just a few minutes.

Fact checked

Apyx Medical Corporation is a medical devices business based in the US. Apyx Medical Corporation shares (APYX) are listed on the NASDAQ and all prices are listed in US Dollars. Apyx Medical Corporation employs 266 staff and has a trailing 12-month revenue of around USD$24.6 million.

How to buy shares in Apyx Medical Corporation

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Apyx Medical Corporation. Find the stock by name or ticker symbol: APYX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Apyx Medical Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Apyx Medical Corporation, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Apyx Medical Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Apyx Medical Corporation share price

Use our graph to track the performance of APYX stocks over time.

Apyx Medical Corporation shares at a glance

Information last updated 2021-02-24.
52-week rangeUSD$2.805 - USD$11.05
50-day moving average USD$9.5656
200-day moving average USD$6.8682
Wall St. target priceUSD$12.5
PE ratio 4.3027
Dividend yield N/A (0%)
Earnings per share (TTM) USD$1.678

Buy Apyx Medical Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Tastyworks
$0
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TradeStation
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Apyx Medical Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Apyx Medical Corporation under- or over-valued?

Valuing Apyx Medical Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Apyx Medical Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Apyx Medical Corporation's P/E ratio

Apyx Medical Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 4x. In other words, Apyx Medical Corporation shares trade at around 4x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Apyx Medical Corporation financials

Revenue TTM USD$24.6 million
Gross profit TTM USD$19.1 million
Return on assets TTM -18.47%
Return on equity TTM -22.41%
Profit margin -64.16%
Book value $1.876
Market capitalisation USD$357.1 million

TTM: trailing 12 months

Shorting Apyx Medical Corporation shares

There are currently 542,033 Apyx Medical Corporation shares held short by investors – that's known as Apyx Medical Corporation's "short interest". This figure is 4.3% up from 519,867 last month.

There are a few different ways that this level of interest in shorting Apyx Medical Corporation shares can be evaluated.

Apyx Medical Corporation's "short interest ratio" (SIR)

Apyx Medical Corporation's "short interest ratio" (SIR) is the quantity of Apyx Medical Corporation shares currently shorted divided by the average quantity of Apyx Medical Corporation shares traded daily (recently around 109723.27935223). Apyx Medical Corporation's SIR currently stands at 4.94. In other words for every 100,000 Apyx Medical Corporation shares traded daily on the market, roughly 4940 shares are currently held short.

However Apyx Medical Corporation's short interest can also be evaluated against the total number of Apyx Medical Corporation shares, or, against the total number of tradable Apyx Medical Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Apyx Medical Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Apyx Medical Corporation shares in existence, roughly 20 shares are currently held short) or 0.0163% of the tradable shares (for every 100,000 tradable Apyx Medical Corporation shares, roughly 16 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Apyx Medical Corporation.

Find out more about how you can short Apyx Medical Corporation stock.

Apyx Medical Corporation share dividends

We're not expecting Apyx Medical Corporation to pay a dividend over the next 12 months.

Apyx Medical Corporation share price volatility

Over the last 12 months, Apyx Medical Corporation's shares have ranged in value from as little as $2.805 up to $11.05. A popular way to gauge a stock's volatility is its "beta".

APYX.US volatility(beta: 0.67)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Apyx Medical Corporation's is 0.667. This would suggest that Apyx Medical Corporation's shares are less volatile than average (for this exchange).

Apyx Medical Corporation overview

Apyx Medical Corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the J-Plasma system allows surgeons to operate in eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site